New drug gets "fast track" from FDA for Chronic Sinuisits

Thread view:

Enable EMail Alerts

Start New Thread

Thread rating:

judy.n - 30 May 2007 15:26 GMT

I found a reference to this in a prescribing newsletter: there is a
link in the article to the NIH clinical trials: from what I can tell,
it appears to be an aminogycoside--as allergy to the class of drugs
will eliminate you from the study.
http://www.marketwatch.com/news/story/fda-approves-fast-track-designation/story.
aspx?guid=%7BA87D14FB-3440-46D9-9FFE-7E82723CED7B%7D
Personally, I was expecting a low dose macrolide.
Anymore info would be appreciated: this is a privately held company.

Judy

Reply to this Message

Steven L. - 31 May 2007 08:09 GMT

> I found a reference to this in a prescribing newsletter: there is a
> link in the article to the NIH clinical trials: from what I can tell,
[quoted text clipped - 3 lines]
> Personally, I was expecting a low dose macrolide.
> Anymore info would be appreciated: this is a privately held company.

IIRC, this is SinuNeb by another name.
IOW, a nebulized formulation of some antibiotic.

Signature

Steven D. Litvintchouk
Email: sdlitvin@earthlinkNOSPAM.net
Remove the NOSPAM before replying to me.

Reply to this Message

judy.n - 01 Jun 2007 01:22 GMT

Thanks, I kind of got that idea from their website--which is short on
details. How is this a "new drug": just another delivery system?
Judy

> > I found a reference to this in a prescribing newsletter: there is a
> > link in the article to the NIH clinical trials: from what I can tell,
[quoted text clipped - 11 lines]
> Email: sdlit...@earthlinkNOSPAM.net
> Remove the NOSPAM before replying to me.

Reply to this Message